Cancer is one of the top expense categories for employers, driven by inaccurate diagnoses, suboptimal treatment plans, expensive novel treatments and excess care.
Benefits leaders want to do the right thing and improve access to the best treatments for their employees, but they also have a responsibility to control costs. In this webinar, we discussed how these two goals are not mutually exclusive—they go hand in hand.
Our panelists:
- Suzanne Dezember Usaj, Senior Director, Total Rewards at The Wonderful Company
- Lalan Wilfong, MD, Senior Vice President, Payer and Care Transformation, The U.S. Oncology Network
- Nicki MacManus, SVP, General Manager, Cancer Care Direct
- Erin Tatar, SVP, Head of Consultant Relations, Employer Direct Healthcare
Key takeaways:
- – Complexity in Cancer Treatment: As Dr. Lalan Wilfong highlighted, “Every week there’s a new marker, a new way we’re treating cancer,” making it challenging for oncologists to stay current, especially outside specialized areas.
- – Rising Healthcare Costs: Suzanne Usaj emphasized the increasing costs for employers, driven by higher cancer incidence and the need for personalized treatments.
- – Supporting Employees: The Wonderful Company selected Cancer Care Direct (now Lantern) for its ability to provide a holistic solution that prioritizes employee support while managing healthcare costs effectively.
